China Stroke Management and Care Market Market Report 2023 to 2030

China Stroke Management and Care Market Analysis

$ 3999

China Stroke Management and Care Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stroke Management and Care is growing as a result of rising prevalence of cardiovascular diseases, growing geriatric population, and advancements in technology. This demand is fueling the development of better care and management for stroke. Some of the key players in the global Stroke Management and Care Market include Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Bristol Myers Squibb Co., Merck & Co., GE Healthcare, Siemens AG, Cardinal Health Inc., GlaxoSmithKline Plc, and Medtronic Plc.

ID: IN10CNHS102 CATEGORY: Healthcare Services GEOGRAPHY: China AUTHOR: Aneri Parekh

Buy Now

China Stroke Management and Care Market Executive Summary

China Stroke Management and Care Market is valued at around $2.96 Bn in 2022 and is projected to reach $6.03 Bn by 2030, exhibiting a CAGR of 9.3% during the forecast period 2023-2030.

Cardiac conditions raise the risk of stroke and coronary artery disease, which frequently results in fatalities or other health issues that cause impairments. According to World Health Organization 2022 report, the risk of developing a stroke has increased by 50% over the last 17 years and 1 in 4 people are now estimated to have a stroke in their lifetime. As a result, there is a significant demand for the market of Stroke Management and Care.

The market for Stroke Management and Care will expand as a result of improvements in stroke diagnosis tools and technologies as well as the discovery of new medications. The stroke management market will soon be dominated by technologies like exoskeleton soft suits for rehabilitation and robotic-assisted angiography.

Pharmaceutical and biotechnology firms like Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Bristol Myers Squibb Co., Merck & Co., GE Healthcare, Siemens AG, Cardinal Health Inc., GlaxoSmithKline Plc, Medtronic Plc, are some of the major players in the Stroke Management and Care Market.

The rise in chronic diseases incidences such as high blood pressure, high cholesterol levels and obesity, heart diseases, diabetes, sickle cell disease, smoking, excessive alcohol, and drug consumption, and the rise in the elderly population are some of the major factors that can increase the chances of strokes and are driving the expansion of the market for Stroke Management and Care.

The market is growing as a result of technological developments in stroke diagnosis and treatment. The lack of reimbursement policies and the high cost of diagnosis and treatment, however, is anticipated to impede market expansion. On the other hand, continuous Research & Development efforts in the area of stroke management are projected to present profitable chances for the market's expansion.

Market Dynamics

Drivers of China Stroke Management and Care Market

Growing Preference for Minimally Invasive Procedures: One of the key factors accelerating the growth and demand of the Stroke Management and Care market is the rapidly rising preference for less invasive techniques
Increasing Prevalence of Cardiovascular Diseases: As the prevalence of cardiovascular diseases increases, the market for Stroke management and Care is projected to grow
Technological Advancement in Stroke Management: The market for stroke management has a lot of potentials as more people are using the MicroTransponder Vivistim Paired VNS System (Vivistim System), the first FDA-approved drug-free treatment for stroke
Rising Geriatric Population: The rise in the geriatric population can drive the market for Stroke Management and Care as older populations are more prone to having a stroke

Restraints of China Stroke Management and Care Market

Stringent Regulatory Framework: The strict rules and regulations in the Stroke Management and Care industry can limit innovation, drive up costs, and extend the time it takes for new technology and treatments to reach the market
High Cost of Procedures: The Stroke Management and Care market may be hampered by the high cost of stroke management methods

Developments in Stroke Management and Care Market

In 2022, Medtronic plc received FDA approval for expanded labeling of a cardiac lead that uses the heart's natural electrical system to deliver therapy to patients while preventing complications like cardiomyopathy sometimes associated with conventional pacing techniques. This method, also known as conduction system pacing, makes sure that pacing closely resembles the heart's natural contractions and enables the ventricles to cooperate.

Key players

Mindray Medical International Limited MicroPort Scientific Corporation Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Chindex Medical Limited (a subsidiary of Fosun Pharma) Sinocare Inc. Shanghai Pharmaceuticals Holding Co., Ltd. Guangzhou Improve Medical Instruments Co., Ltd. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Asahi Kasei Corporation Sichuan Kelun Pharmaceutical Co., Ltd.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For China Stroke Management and Care Market

By Product Type

Diagnostic
Therapeutics

By Application

Ischemic Stroke
Hemorrhagic Stroke

By End-user

Hospitals
Clinics
Retail Pharmacies
Ambulatory Surgical Centers
Diagnostic Laboratories
Online Pharmacies
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.